BB Biotech AG | Balance Sheet

Fiscal year is January-December. All values CHF Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
2,211
3,533
4,131
3,211
3,638
Total Assets
2,211
3,533
4,144
3,226
3,638
Other Liabilities
2
10
6
18
4
Total Liabilities
92
40
166
223
99
Common Equity (Total)
2,119
3,493
3,978
3,003
3,539
Total Shareholders' Equity
2,119
3,493
3,978
3,003
3,539
Total Equity
2,119
3,493
3,978
3,003
3,539
Liabilities & Shareholders' Equity
2,211
3,533
4,144
3,226
3,638
Short-Term Receivables
-
-
4
10
-
Investments - Total
-
-
9
5
-
Other Assets (Including Intangibles)
-
-
-
-
-
Total Debt
90
30
160
205
95

About BB Biotech

View Profile
Address
Schwertstrasse 6
Schaffhausen Zurich 8200
Switzerland
Employees -
Website http://www.bbbiotech.com
Updated 09/14/2018
BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on companies whose products address areas of significant unmet medical needs and generates above-average sales and profit growth. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.